Find Marizomib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Salinosporamide a, 437742-34-2, Npi-0052, (-)-salinosporamide a, Npi 0052, Ml 858
Molecular Formula
C15H20ClNO4
Molecular Weight
313.77  g/mol
InChI Key
NGWSFRIPKNWYAO-SHTIJGAHSA-N
FDA UNII
703P9YDP7F

Marizomib
Marizomib is a naturally-occurring salinosporamide, isolated from the marine actinomycete Salinospora tropica, with potential antineoplastic activity. Marizomib irreversibly binds to and inhibits the 20S catalytic core subunit of the proteasome by covalently modifying its active site threonine residues; inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis. This agent more may more potent and selective than the proteasome inhibitor bortezomib.
1 2D Structure

Marizomib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
2.1.2 InChI
InChI=1S/C15H20ClNO4/c1-14-10(7-8-16)12(19)17-15(14,13(20)21-14)11(18)9-5-3-2-4-6-9/h3,5,9-11,18H,2,4,6-8H2,1H3,(H,17,19)/t9-,10+,11+,14+,15+/m1/s1
2.1.3 InChI Key
NGWSFRIPKNWYAO-SHTIJGAHSA-N
2.1.4 Canonical SMILES
CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl
2.1.5 Isomeric SMILES
C[C@]12[C@H](C(=O)N[C@]1(C(=O)O2)[C@H]([C@H]3CCCC=C3)O)CCCl
2.2 Other Identifiers
2.2.1 UNII
703P9YDP7F
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Homosalinosporamide A

2. Npi 0052

3. Npi-0052

4. Salinosporamide A

2.3.2 Depositor-Supplied Synonyms

1. Salinosporamide A

2. 437742-34-2

3. Npi-0052

4. (-)-salinosporamide A

5. Npi 0052

6. Ml 858

7. Salinosporamide A (npi-0052, Marizomib)

8. 703p9ydp7f

9. Chebi:48045

10. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-en-1-yl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione

11. (1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione

12. Marizomib [usan:inn]

13. Marizomibum

14. Unii-703p9ydp7f

15. Homosalinosporamide A

16. Marizomib [inn]

17. Marizomib (usan/inn)

18. Marizomib [usan]

19. Marizomib [who-dd]

20. Schembl151667

21. Salinosporamide A [mi]

22. Chembl371405

23. Dtxsid00904019

24. (1s,2r,5r)-2-(2-chloroethyl)-5-[(s)-[(1s)-cyclohex-2-en-1-yl]-hydroxymethyl]-1-methyl-7-oxa-4-azabicyclo[3.2.0]heptane-3,6-dione

25. Ex-a3259

26. Zinc3990364

27. Bdbm50398608

28. Akos027323566

29. Db11762

30. Hy-10985

31. Cs-0002986

32. D09640

33. A872651

34. Q7404722

35. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((1s)-cyclohex-2-en-1-yl)hydroxymethyl)-5-methyl- 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione

36. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-enyl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione

37. (1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-[(1s)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione

38. 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione, 4-(2-chloroethyl)-1-((s)-(1s)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1r,4r,5s)-

39. 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione, 4-(2-chloroethyl)-1-((s)-(1s)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1r,4r,5s)-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 313.77 g/mol
Molecular Formula C15H20ClNO4
XLogP31.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass313.1080858 g/mol
Monoisotopic Mass313.1080858 g/mol
Topological Polar Surface Area75.6 Ų
Heavy Atom Count21
Formal Charge0
Complexity508
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of malignant glial tumours


ABOUT THIS PAGE

Looking for 437742-34-2 / Marizomib API manufacturers, exporters & distributors?

Marizomib manufacturers, exporters & distributors 1

74

PharmaCompass offers a list of Marizomib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Marizomib manufacturer or Marizomib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Marizomib manufacturer or Marizomib supplier.

PharmaCompass also assists you with knowing the Marizomib API Price utilized in the formulation of products. Marizomib API Price is not always fixed or binding as the Marizomib Price is obtained through a variety of data sources. The Marizomib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Marizomib

Synonyms

Salinosporamide a, 437742-34-2, Npi-0052, (-)-salinosporamide a, Npi 0052, Ml 858

Cas Number

437742-34-2

Unique Ingredient Identifier (UNII)

703P9YDP7F

About Marizomib

Marizomib is a naturally-occurring salinosporamide, isolated from the marine actinomycete Salinospora tropica, with potential antineoplastic activity. Marizomib irreversibly binds to and inhibits the 20S catalytic core subunit of the proteasome by covalently modifying its active site threonine residues; inhibition of ubiquitin-proteasome mediated proteolysis results in an accumulation of poly-ubiquitinated proteins, which may result in the disruption of cellular processes, cell cycle arrest, the induction of apoptosis, and the inhibition of tumor growth and angiogenesis. This agent more may more potent and selective than the proteasome inhibitor bortezomib.

NPI 0052 Manufacturers

A NPI 0052 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NPI 0052, including repackagers and relabelers. The FDA regulates NPI 0052 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NPI 0052 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of NPI 0052 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

NPI 0052 Suppliers

A NPI 0052 supplier is an individual or a company that provides NPI 0052 active pharmaceutical ingredient (API) or NPI 0052 finished formulations upon request. The NPI 0052 suppliers may include NPI 0052 API manufacturers, exporters, distributors and traders.

click here to find a list of NPI 0052 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

NPI 0052 USDMF

A NPI 0052 DMF (Drug Master File) is a document detailing the whole manufacturing process of NPI 0052 active pharmaceutical ingredient (API) in detail. Different forms of NPI 0052 DMFs exist exist since differing nations have different regulations, such as NPI 0052 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A NPI 0052 DMF submitted to regulatory agencies in the US is known as a USDMF. NPI 0052 USDMF includes data on NPI 0052's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NPI 0052 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of NPI 0052 suppliers with USDMF on PharmaCompass.

NPI 0052 GMP

NPI 0052 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of NPI 0052 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NPI 0052 GMP manufacturer or NPI 0052 GMP API supplier for your needs.

NPI 0052 CoA

A NPI 0052 CoA (Certificate of Analysis) is a formal document that attests to NPI 0052's compliance with NPI 0052 specifications and serves as a tool for batch-level quality control.

NPI 0052 CoA mostly includes findings from lab analyses of a specific batch. For each NPI 0052 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

NPI 0052 may be tested according to a variety of international standards, such as European Pharmacopoeia (NPI 0052 EP), NPI 0052 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NPI 0052 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty